Dr. Reddy'S Laboratories (RDY) news
Recent news
Dr. Reddy's issued Form 483 with three observations for FT0-9
Dr. Reddy’s Laboratories Ltd. has received a Form 483 from the U.S. Food and Drug Administration (USFDA) for its formulations manufacturing facility, FT0-9, following an inspection. The company disclosed the development in a regulatory filing, indicating that the inspection included both Good…
AInvest Wire · 1d agoDR Reddy's - USFDA completed a pre approval inspection at FTO-9 manufacturing facility in Visakhapatnam
AInvest Wire · 1d agoDR Reddy's - Got a Form 483 with three observations from US FDA
AInvest Wire · 1d agoMalaysia's Mr D.I.Y. Group ends 3.4% higher at MYR 1.23, top percentage gainer on KLCI
Malaysia's Mr D.I.Y. Group (M) Bhd (MRDIY) closed 3.4% higher at MYR 1.23 on October 13, 2026, emerging as the top percentage gainer on the Kuala Lumpur Composite Index (KLCI). The stock's performance followed a recent uptick in investor interest, with some market participants noting the potential…
AInvest Wire · 2d agoUK's Sunak: India has great opportunity in pharma supply chains
Union Indian Commerce and Industry Minister Piyush Goyal has emphasized that the United Kingdom presents significant export opportunities for India, particularly in the pharmaceutical sector. Speaking at the India-UK JETCO Business Plenary, Goyal highlighted the complementary nature of the two…
AInvest Wire · 2d agoLight Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.